Cai Y - Search Results

1

N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives.

Xu Z, Peng B, Cai Y, Wu G, Huang J, Gao M, Guo G, Zeng S, Gong Z, Yan Y. Xu Z, et al. Among authors: cai y. Biochem Pharmacol. 2020 Dec;182:114258. doi: 10.1016/j.bcp.2020.114258. Epub 2020 Oct 2. Biochem Pharmacol. 2020. PMID: 33017575 Review.

2

Rheostatic Balance of Circadian Rhythm and Autophagy in Metabolism and Disease.

Wang X, Xu Z, Cai Y, Zeng S, Peng B, Ren X, Yan Y, Gong Z. Wang X, et al. Among authors: cai y. Front Cell Dev Biol. 2020 Nov 24;8:616434. doi: 10.3389/fcell.2020.616434. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33330516 Free PMC article. Review.

3

Expression and molecular profiles of the AlkB family in ovarian serous carcinoma.

Cai Y, Wu G, Peng B, Li J, Zeng S, Yan Y, Xu Z. Cai Y, et al. Aging (Albany NY). 2021 Mar 19;13(7):9679-9692. doi: 10.18632/aging.202716. Epub 2021 Mar 19. Aging (Albany NY). 2021. PMID: 33744868 Free PMC article.

4

Use of cucurbitacins for lung cancer research and therapy.

Liu M, Yan Q, Peng B, Cai Y, Zeng S, Xu Z, Yan Y, Gong Z. Liu M, et al. Among authors: cai y. Cancer Chemother Pharmacol. 2021 Jul;88(1):1-14. doi: 10.1007/s00280-021-04265-7. Epub 2021 Apr 6. Cancer Chemother Pharmacol. 2021. PMID: 33825035 Review.

5

ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis.

Wu G, Yan Y, Cai Y, Peng B, Li J, Huang J, Xu Z, Zhou J. Wu G, et al. Among authors: cai y. Front Cell Dev Biol. 2021 Jun 3;9:633927. doi: 10.3389/fcell.2021.633927. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34150745 Free PMC article.

6

Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications.

Zhou Z, Peng B, Li J, Gao K, Cai Y, Xu Z, Yan Y. Zhou Z, et al. Among authors: cai y. Sci Rep. 2021 Sep 15;11(1):18366. doi: 10.1038/s41598-021-97840-0. Sci Rep. 2021. PMID: 34526571 Free PMC article.

7

Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.

Xu Z, Peng B, Liang Q, Chen X, Cai Y, Zeng S, Gao K, Wang X, Yi Q, Gong Z, Yan Y. Xu Z, et al. Among authors: cai y. Front Immunol. 2021 Sep 17;12:719175. doi: 10.3389/fimmu.2021.719175. eCollection 2021. Front Immunol. 2021. PMID: 34603293 Free PMC article.

8

Evaluation of Ferroptosis-related Gene AKR1C1 as a Novel Biomarker Associated with the Immune Microenvironment and Prognosis in Breast Cancer.

Zhang Z, Qiu X, Yan Y, Liang Q, Cai Y, Peng B, Xu Z, Xia F. Zhang Z, et al. Among authors: cai y. Int J Gen Med. 2021 Sep 28;14:6189-6200. doi: 10.2147/IJGM.S329031. eCollection 2021. Int J Gen Med. 2021. PMID: 34611432 Free PMC article.

9

BTB/POZ domain-containing protein 7/hypoxia-inducible factor 1 alpha signalling axis modulates hepatocellular carcinoma metastasis.

Hu K, Li J, Wang Z, Yan Y, Cai Y, Peng B, Huang J, He D, Zhou L, Xu Z, Tao Y. Hu K, et al. Among authors: cai y. Clin Transl Med. 2021 Oct;11(10):e556. doi: 10.1002/ctm2.556. Clin Transl Med. 2021. PMID: 34709740 Free PMC article. No abstract available.

10

Significance of TEAD Family in Diagnosis, Prognosis and Immune Response for Ovarian Serous Carcinoma.

Ren X, Wang X, Peng B, Liang Q, Cai Y, Gao K, Hu Y, Xu Z, Yan Y. Ren X, et al. Among authors: cai y. Int J Gen Med. 2021 Oct 27;14:7133-7143. doi: 10.2147/IJGM.S336602. eCollection 2021. Int J Gen Med. 2021. PMID: 34737608 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,323 results

Search Page

Filters